Authors:
Fujita, T
Toya, Y
Iwatsubo, K
Onda, T
Kimura, K
Umemura, S
Ishikawa, Y
Citation: T. Fujita et al., Accumulation of molecules involved in alpha 1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy, CARDIO RES, 51(4), 2001, pp. 709-716
Authors:
Schwencke, C
Yamamoto, M
Okumura, S
Toya, Y
Kim, SJ
Ishikawa, Y
Citation: C. Schwencke et al., Compartmentation of cyclic adenosine 3 ',5 '-monophosphate signaling in caveolae, MOL ENDOCR, 13(7), 1999, pp. 1061-1070
Authors:
Ishigami, T
Tamura, K
Fujita, T
Kobayashi, I
Hibi, K
Kihara, M
Toya, Y
Ochiai, H
Umemura, S
Citation: T. Ishigami et al., Angiotensinogen gene polymorphism near transcription start site and blood pressure - Role of a T-to-C transition at intron I, HYPERTENSIO, 34(3), 1999, pp. 430-434
Authors:
Kihara, M
Yabana, M
Toya, Y
Kobayashi, S
Fujita, T
Iwamoto, T
Ishigami, T
Uemura, S
Citation: M. Kihara et al., Angiotensin II inhibits interleukin-1 beta-induced nitric oxide productionin cultured rat mesangial cells, KIDNEY INT, 55(4), 1999, pp. 1277-1283
Authors:
Yabana, M
Kihara, M
Toya, Y
Tamura, K
Takagi, N
Kurita, K
Onishi, M
Umemura, S
Citation: M. Yabana et al., Control of high hematocrit levels in a hemodialysis patient with an angiotensin-converting enzyme inhibitor, NEPHRON, 83(2), 1999, pp. 181-182
Authors:
Tamura, K
Takagi, N
Yabana, M
Kihara, M
Toya, Y
Takizawa, T
Takeshita, Y
Tokita, Y
Inayama, Y
Umemura, S
Citation: K. Tamura et al., Nephrotic syndrome due to membranous glomerulonephritis in a patient with idiopathic thrombocytopenic purpura, NEPHRON, 82(1), 1999, pp. 87-89
Authors:
Yabana, M
Kihara, M
Toya, Y
Tamura, K
Matsumoto, K
Takagi, N
Kamijo, S
Ishii, M
Umemura, S
Citation: M. Yabana et al., Simultaneous improvement of minimal-change nephrotic syndrome and anemia with steroid therapy, NEPHRON, 81(1), 1999, pp. 84-88
Authors:
Yabana, M
Ikeda, Y
Kihara, M
Kurita, K
Toya, Y
Tamura, K
Takagi, N
Onishi, T
Umemura, S
Citation: M. Yabana et al., Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment, NEPHRON, 81(1), 1999, pp. 111-112